MTOR and metabolic dysfunction-associated steatotic liver disease: BCAAs promote adipose tissue activity, NAFLD, and insulin resistance via mTOR-S6K (mammalian target of rapamycin—S6 kinase) [268,269], and conversely, insulin resistance increases circulating BCAA levels by reduced amino acid metabolization [270,271].